Addex Therapeutics 报告称，第三季度亏损 154 万美元，与之前的一次性利润形成鲜明对比。 Addex Therapeutics reports a $1.54 million loss in Q3, contrasting a previous one-time profit.

瑞士生物制药公司Addex Therapeutics在2024年第三季度报告净亏损154万美元,较第二季度的净利1290万美元大幅下降,原因是出售部分业务的一次性收益. Addex Therapeutics, a Swiss biopharmaceutical company, reported a net loss of $1.54 million in the third quarter of 2024, a significant drop from the second quarter's net profit of $12.9 million due to a one-time gain from selling part of its business. 尽管如此,该公司九个月的业绩仍然显示净利润为830万美元。 Despite this, the company's nine-month results still show a net profit of $8.3 million. 最后的第三季度结果将于11月22日公布。 The final third-quarter results will be released on November 22.